NCT00117507View on ClinicalTrials.gov

Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Myelodysplastic SyndromesIron Overload
Interventions
DRUG

Deferasirox

Trial Locations (3)

48201

Karmanos Cancer Center, Detroit

94305-5821

Stanford University Medical Center, Stanford

77030-4009

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY